New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat [Yahoo! Finance]
Accuray Incorporated (ARAY)
Last accuray incorporated earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.accuray.com/investor-overview
Company Research
Source: Yahoo! Finance
be an effective and safe treatment option for brainstem metastases, a challenging location to treat. The study, which analyzed data from 136 patients, showed that stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) delivered with the CyberKnife System provided high local control rates, with 82.9% of patients experiencing local control at one year, 71.4% at two years, and 61.2% at three years. The treatment was also well-tolerated, with a low incidence of treatment-related side effects. Generated by Yahoo Finance AI Yahoo Finance used generative AI to summarize key information from this article. Some details may be inaccurate. We take that seriously. Reporting mistakes helps us improve these summaries. Was this helpful? Yes No Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications MADISON, Wis. Dec. 18, 2024 /PRNewswire/ -- Accuray Incorpor
Show less
Read more
Impact Snapshot
Event Time:
ARAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARAY alerts
High impacting Accuray Incorporated news events
Weekly update
A roundup of the hottest topics
ARAY
News
- Accuray Loses US$24m Market Value But Insiders See Windfall Of US$23k [Yahoo! Finance]Yahoo! Finance
- Reasons to Add McKesson Stock to Your Portfolio Right Now [Yahoo! Finance]Yahoo! Finance
- Ablation Technology Market Insights, Key Drivers and Opportunities | Exactitude Consultancy [Yahoo! Finance]Yahoo! Finance
- New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to TreatPR Newswire
- Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY) [Yahoo! Finance]Yahoo! Finance
ARAY
Earnings
- 11/6/24 - In-Line
ARAY
Sec Filings
- 12/11/24 - Form 8-K
- 12/9/24 - Form 3
- 12/3/24 - Form 4
- ARAY's page on the SEC website